| Dictionary, Encyclopedia and Thesaurus - The Free Dictionary 1,785,562,996 visitors served. |
|
Dictionary/ thesaurus | Medical dictionary | Legal dictionary | Financial dictionary | Acronyms | Idioms | Encyclopedia | Wikipedia encyclopedia | ? |
gemcitabine |
Also found in: Wikipedia | 0.01 sec. |
|
gemcitabine /gem·cit·a·bine/ (jem-sit´ah-bēn) an antineoplastic agent used as the hydrochloride salt in the treatment of pancreatic adenocarcinoma and non. gemcitabine, a miscellaneous antineoplastic. indications It is used to treat adenocarcinoma of the pancreas (nonresectable Stages II and III or metastatic Stage IV) and non-small-cell lung cancer (Stages IIIA or B and IV). It is also used in combination with cisplatin to treat inoperable, advanced, or metastatic non-small-cell lung cancer. contraindications Known hypersensitity and pregnancy prohibit its use. adverse effects Life-threatening effects are leukopenia, anemia, neutropenia, thrombocytopenia, and hemorrhage. Other adverse effects include diarrhea, nausea, vomiting, anorexia, constipation, stomatitis, irritation at the site of administration, rash, alopecia, dyspnea, fever, and infection. gemcitabine How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content. |
|
| ? Mentioned in | ? References in periodicals archive | ||
|---|---|---|---|
| Tokyo, Japan, July 11, 2006 - (JCN) - Eli Lilly Japan announced o June 4 that it has obtained additional approval for Gemzar Injection (gemcitabine HC1), its proprietary anti-cancer agent, from the Ministry of Health, Labor and Welfare. s Gemzar is the first new treatment for pancreatic cancer in 30 years. Market uptake of new internally-developed products (Alimta, Strattera, and Forteo), continued strong revenue growth of Gemzar and Evista, along with the moderation of the Zyprexa sales decline and benefits of restructuring actions will also more or less offset a sustained high level of investment dedicated to advancing the R&D pipeline, and royalties given to marketing partners of newer in-licensed products, specifically Cymbalta and Byetta. |
| Medical Dictionary |
| Free Tools: |
For surfers:
Free toolbar & extensions |
Word of the Day |
Help
For webmasters: Free content | Linking | Lookup box | Double-click lookup | Partner with us |
|---|